Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Breast surgery

Location and Subtypes: Central, Peripheral, and Juvenile Papillomatosis

At a Glance

Breast papillomas may be central, near the nipple, or peripheral, deeper in the breast; multiple lesions can be harder to sample. Juvenile papillomatosis is a separate benign diagnosis that may warrant family-history review and individualized follow-up.

While all intraductal papillomas involve growths inside the milk ducts, their “neighborhood” within the breast—and the age at which they appear—can change how your medical team manages them. Doctors distinguish between central and peripheral locations and identify rare subtypes like juvenile papillomatosis to better understand your future health risks [1][2].

Central vs. Peripheral Papillomas

The location of a papilloma often dictates the symptoms you experience and how the growth is first discovered.

  • Central Papillomas: These are usually located in the large milk ducts directly behind the nipple (the retroareolar area) [1]. They are often “solitary,” meaning there is only one. Because they are in larger ducts, they frequently cause symptoms like a palpable mass or spontaneous nipple discharge, which may be clear or bloody [2][3].
  • Peripheral Papillomas: These are found deeper in the breast tissue, further away from the nipple [2]. They are often smaller and “multiple” (papillomatosis). These growths are frequently “silent,” meaning they cause no symptoms and are only found on a mammogram or ultrasound, sometimes appearing as tiny calcium deposits (microcalcifications) [2][3].

Why Multiplicity Matters

When you have multiple papillomas (papillomatosis), your care team may be more cautious. Having multiple growths can make it harder to ensure that a small needle biopsy has captured the most “active” part of the area or adequately sampled every lesion [4]. While multiplicity alone does not mean you have cancer, some studies suggest that having four or more papillomas may be associated with a higher risk of finding atypia or cancer during surgery, supporting an individualized clinical assessment [5][6].

Juvenile Papillomatosis (Swiss-Cheese Disease)

(Note: This section only applies if your pathology report explicitly diagnoses “Juvenile Papillomatosis”. It is not simply multiple papillomas in a young person, and imaging alone cannot establish JP; it requires a specific pathology diagnosis.)

Juvenile papillomatosis (JP) is a rare, benign, but very distinct form of composite breast lesion. It primarily affects young women and adolescents, typically those under the age of 30 [7][8].

The “Swiss-Cheese” Appearance

This condition earned the nickname Swiss-cheese disease because of how it looks on an ultrasound or under a microscope. Rather than one solid mass, it appears as a cluster of many small cysts and dense tissue [9]. Its biological features include:

  • Multiple Cysts: Fluid-filled sacs of various sizes [8].
  • Duct Ectasia: Widened or “dilated” milk ducts [9].
  • Florid Hyperplasia: A significant overgrowth of the cells lining the ducts [8].
  • Papillary Changes: The finger-like growths common to all papillomas [10].

Because it often presents as a firm, moveable lump, it is frequently mistaken for a fibroadenoma (a much more common benign breast lump in young women) until a biopsy or surgery is performed [11][10].

Family History and Future Risk

Juvenile papillomatosis is unique because it is often linked to a strong family history of breast cancer. About 20% to 28% of patients with JP have a close relative who has had breast cancer [8][9].

While JP itself is benign, its presence—especially when combined with a family history—may indicate a higher lifetime risk of developing breast cancer later on [9]. Older historical reviews noted that in about 10% of cases, cancer may be found at the same time as the JP, and in another 10%, it may develop years later [8]. However, it is important to understand that these statistics come from older, small, heterogeneous series, and the absolute future risk attributable to the JP lesion itself is uncertain. Family history may be the more important risk signal. A diagnosis of JP alone does not automatically require high-risk clinic monitoring, but young women with this diagnosis are often referred to discuss whether genetic counseling or high-risk monitoring is appropriate [12][10].

Summary of Risk and Management

Whether your papillomas are central, peripheral, or part of juvenile papillomatosis, the goal of your care team is the same: radiology-pathology concordance [13]. They want to be certain that the tissue sample they took truly represents the entire area seen on your scans. If there is any doubt—or if “high-risk” features like atypia are found—they will likely recommend removing the area to be safe [5][14].

Common questions in this guide

How are central and peripheral breast papillomas different?
Central papillomas grow in the large ducts behind the nipple and are often single, so they may cause a lump or clear or bloody nipple discharge. Peripheral papillomas are deeper in the breast, are more often multiple, and may be found only on mammography or ultrasound.
Does having multiple breast papillomas mean I have cancer?
No. Multiple papillomas are not cancer by themselves, but they can make it harder for a needle biopsy to sample every important area. Some studies suggest that having four or more lesions may increase the chance of atypical cells or cancer being found at surgery, so your care team may recommend individualized review or removal when concerns are present.
What is juvenile papillomatosis, and is it the same as having multiple papillomas?
Juvenile papillomatosis is a rare, benign breast lesion that usually affects adolescents and young women and contains small cysts, widened ducts, dense tissue, and papillary changes. It is not simply multiple papillomas in a young person; a pathology diagnosis is needed, and imaging alone cannot confirm it.
Can juvenile papillomatosis raise my future breast cancer risk?
Juvenile papillomatosis is benign, but it can occur alongside a strong family history of breast cancer. Older small studies reported cancer in some patients at the same time or years later, but the added risk from the lesion itself remains uncertain. Discuss your family history with your breast specialist to decide whether genetic counseling or high-risk monitoring is appropriate.
Why does my doctor compare the biopsy with my breast imaging?
Your care team compares the biopsy result with the mammogram or ultrasound to check that the sample explains the area seen on the images. If the results do not match, or if atypical cells are found, they may recommend removing the area for a more complete examination.
When should I ask about genetic counseling after a papillomatosis diagnosis?
Ask about genetic counseling or a high-risk breast clinic if you have juvenile papillomatosis and a close relative with breast cancer, particularly cancer diagnosed at a young age. A specialist can review your family history and help decide whether high-risk monitoring is appropriate.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on intraductal breast papillomatosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Are my papillomas located centrally (near the nipple) or peripherally (deeper in the breast)?
  2. 2.Because I have multiple papillomas, how does that affect the accuracy of the biopsy we performed?
  3. 3.Does my pathology specifically match the criteria for 'juvenile papillomatosis' or is it ordinary multiple papillomas?
  4. 4.Given my family history and this diagnosis, would I benefit from a consultation with a genetic counselor or a high-risk breast clinic?

References

References (14)
  1. 1

    Unusual presentation of intraductal papilloma on the nipple: A case report.

    Rahman NA, Arnaout I, Krimsti M, et al.

    International journal of surgery case reports 2024; (117()):109483 doi:10.1016/j.ijscr.2024.109483.

    PMID: 38493616
  2. 2

    Papillomas of the breast: factors associated with underestimation.

    Boufelli G, Giannotti MA, Ruiz CA, et al.

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2018; (27(4)):310-314 doi:10.1097/CEJ.0000000000000343.

    PMID: 28296665
  3. 3

    Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: Scoring system for predicting malignancy.

    Ahn SK, Han W, Moon HG, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2018; (44(1)):53-58 doi:10.1016/j.ejso.2017.10.214.

    PMID: 29174198
  4. 4

    Treatment Strategy for Breast Benign Intraductal Papilloma: A Meta-Analysis.

    Lou C, Wang W, Zhou B

    Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2024; (43(3)):39-49 doi:10.1615/JEnvironPatholToxicolOncol.2024052888.

    PMID: 38608144
  5. 5

    Analysis of 612 Benign Papillomas Diagnosed at Core Biopsy: Rate of Upgrade to Malignancy, Factors Associated With Upgrade, and a Proposal for Selective Surgical Excision.

    Lee SJ, Wahab RA, Sobel LD, et al.

    AJR. American journal of roentgenology 2021; (217(6)):1299-1311 doi:10.2214/AJR.21.25832.

    PMID: 34008998
  6. 6

    Benign Intraductal Papilloma without Atypia on Core Needle Biopsy Has a Low Rate of Upgrading to Malignancy after Excision.

    Han SH, Kim M, Chung YR, et al.

    Journal of breast cancer 2018; (21(1)):80-86 doi:10.4048/jbc.2018.21.1.80.

    PMID: 29628987
  7. 7

    Juvenile Papillomatosis of the Breast in a Pre-Pubertal Girl: An Uncommon Diagnosis.

    Kafadar MT, Anadolulu Z, Anadolulu Aİ, Tarini EZ

    European journal of breast health 2018; (14(1)):51-53 doi:10.5152/ejbh.2017.3828.

    PMID: 29322120
  8. 8

    Juvenile Papillomatosis (Swiss-Cheese Disease) of Breast in an Adult Male With Sequential Diagnoses of Ipsilateral Intraductal, Invasive, and Widely Metastatic Carcinoma: A Case Report and Review of the Disease in Males.

    Viswanathan K, McMillen B, Cheng E, et al.

    International journal of surgical pathology 2017; (25(6)):536-542 doi:10.1177/1066896917705198.

    PMID: 28420303
  9. 9

    Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutations.

    Guillet C, Rechsteiner M, Bellini E, et al.

    Human pathology 2020; (98()):64-73 doi:10.1016/j.humpath.2020.02.002.

    PMID: 32088208
  10. 10

    Juvenile Papillomatosis of the Breast: a Report of Two Cases with Review of the literature.

    Al-Qurashi M, Ibrahim A, ElSharkawy TM, et al.

    Medical archives (Sarajevo, Bosnia and Herzegovina) 2024; (78(2)):170-173 doi:10.5455/medarh.2024.78.170-173.

    PMID: 38566878
  11. 11

    Fibroepithelial Neoplasm with Hybrid Features of Benign Phyllodes Tumor, Juvenile Papillomatosis, and Juvenile Fibroadenoma: A Case Report.

    Liu BL, Mehrotra M, Kowtha L, et al.

    International journal of surgical pathology 2025; (33(1)):220-228 doi:10.1177/10668969241256112.

    PMID: 38839253
  12. 12

    [Rare benign breast tumors including Abrikossoff tumor (granular cell tumor), erosive adenomatosis of the nipple, cytosteatonecrosis, fibromatosis (desmoid tumor), galactocele, hamartoma, hemangioma, lipoma, juvenile papillomatosis, pseudoangiomatous hyperplasia, and syringomatous adenoma: Guidelines for clinical practice].

    Canlorbe G, Bendifallah S

    Journal de gynecologie, obstetrique et biologie de la reproduction 2015; (44(10)):1030-48.

    PMID: 26530177
  13. 13

    The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).

    Nakhlis F, Baker GM, Pilewskie M, et al.

    Annals of surgical oncology 2021; (28(5)):2573-2578 doi:10.1245/s10434-020-09215-w.

    PMID: 33047246
  14. 14

    Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis.

    Zhang X, Liu W, Hai T, Li F

    Annals of surgical oncology 2021; (28(13)):8643-8650 doi:10.1245/s10434-021-10188-7.

    PMID: 34331160

This page is for informational purposes only and does not constitute medical advice. Your radiologist, pathologist, and breast specialist should interpret your imaging, biopsy, family history, and follow-up needs.